Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of parkinson disease

Journal of Neuropathology and Experimental Neurology

Volumn 66, Issue 7, 2007, Pages 576-584

  Cepeda, Ivan L ^a   Flores, Joseph ^a   Cornfeldt, Michael L ^c   O'Kusky, John R ^b   Doudet, Doris J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Cell Therapy   (Canada)

Author keywords

Basal ganglia; Parkinsonism; Retinal pigment epithelium; Striatum; Transplantation

Indexed keywords

OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; EXPERIMENTAL MODEL; FORELIMB; HINDLIMB; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PIGMENT CELL; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; CELL TRANSPLANTATION; COCAINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; EXTREMITIES; FUNCTIONAL LATERALITY; HUMANS; MALE; MOTOR NEURON DISEASE; PARKINSON DISEASE; PIGMENT EPITHELIUM OF EYE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 34447321864     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/nen.0b013e318093e521     Document Type: Article

References (33)

1. Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: A decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004;10:1055-63
2. Hornykiewicz O. Advances in neurochemistry and pharmacology of Parkinson's disease. In: Cotzias GC, McDowell FH, eds. Developments in Treatment for Parkinson's Disease. New York: Medcom Press, 1971:24-49
3. Hornykiewicz O. Chemical neuroanatomy of the basal ganglia - Normal and in Parkinson's disease. J Chem Neuroanat 2001;22:3-12
4. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(Suppl):S125-27
5. Watts RL, Raiser CD, Stover NP, et al. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: A potential new cell therapy for Parkinson's disease. J Neural Transm Suppl 2003:215-27
6. Marmor MF, Wolfensberger TJ. Structure, Function, and Disease of the Retinal Pigment Epithelium. New York: Oxford University Press, 1998
7. Pawelek JM, Korner AM. The biosynthesis of mammalian melanin. Am Sci 1982;70:136-45
8. Boulton M. Melanin and the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ, eds. Structure, Function, and Disease of the Retinal Pigment Epithelium. New York: Oxford University Press, 1998:68-85
9. Dryja TP, O'Neil-Dryja M, Pawelek JM, et al. Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium. Invest Ophthalmol Vis Sci 1978;17:511-14
10. Smith SB, Zhou BK, Orlow SJ. Expression of tyrosinase and the tyrosinase related proteins in the Mitfvit (vitiligo) mouse eye: Implications for the function of the microphthalmia transcription factor. Exp Eye Res 1998;66:403-10
11. Subramanian T, Marchionini D, Potter EM, et al. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant 2002;11:207-14
12. Cherksey DB, Sapirstein VS, Geraci AL. Adrenal chromaffin cells on microcarriers exhibit enhanced long-term functional effects when implanted into the mammalian brain. Neuroscience 1996;75:657-64
13. Bakay RA, Raiser CD, Stover NP, et al. Implantation of Spheramine in advanced Parkinson's disease (PD). Front Biosci 2004;9:592-602
14. Stover NP, Bakay RAE, Subramanian T, et al. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease. Arch Neurol 2005;62:1833-37
15. Subramanian T. Cell transplantation for the treatment of Parkinson's disease. Semin Neurol 2001;21:103-15
16. Doudet DJ, Cornfeldt ML, Honey CR, et al. PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease. Exp Neurol 2004;189:361-68
17. Schallert T, Tillerson JL. Intervention strategies for degeneration of dopamine neurons in parkinsonism: Optimizing behavioral assessment of outcome. In: Emerich DF, Dean PR, Sanberg PR, eds. Central Nervous System Disease. Totowa, NJ: Humana Press, 2000:131-51
18. Schallert T, Woodlee MT, Fleming SM. Disentangling multiple types of recovery from brain injury. In: Krieglstein J, Klumpp S, eds. Pharmacology of Cerebral Ischemia. Stuttgart: Medpharm Scientific Publishers, 2002:201-16
19. Cepeda IL, Flores J, Cornfeldt ML, et al. Intrastriatal implantation of microcarrier attached human retinal pigment epithelial cells ameliorates motor deficits in a rat model of Parkinson's disease (Abstract). Parkinsonism Relat Disord 2005;11(Suppl 2):139
20. Flores J, Cepeda IL, Cornfeldt ML, et al. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson's disease. J Neuropath Exp Neurol 2007;66:00-00
21. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press, 1997
22. Schallert T, Woodlee MT. Orienting and placing. In: Whishaw IQ, Kolb B, eds. The Behavior of the Laboratory Rat: A Handbook With Tests. New York: Oxford University Press, 2005:129-40
23. 18F] radioligands: The effects of chronic desipramine treatment on serotonin 5-HT2 receptors. J Neurosci Methods 2005;141:143-54
24. Castaneda E, Fleming S, Paquette MA, et al. Assessment of recovery in the hemiparkinson rat: Drug-induced rotation is inadequate. Physiol Behav 2005;84:525-35
25. Cepeda IL, Doudet DJ. Behavioral characterization of normal Sprague Dawley rat's forelimb and hindlimb motor function with two sensorimotor tests sensitive to nigrostriatal integrity (Abstract). Soc Neurosci Abstr 2005;517:2
26. Fleming SM, Delville Y. Schallert T. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: Antiparkinson effects of Sinemet and protective effects of methylphenidate. Behav Brain Res 2005;156:201-13
27. Lundblad M, Andersson M, Winkler C, et al. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 2002;15:120-32
28. Przedborski S. Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism Relat Disord 2005;11:S3-S7
29. Jorgensen A, Wiencke AK, la Cour M, et al. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci 1998;39:1590-99
30. Arnhold S, Semkova I, Andressen C, et al. Iris pigment epithelial cells: A possible cell source for the future treatment of neurodegenerative diseases. Exp Neurol 2004;187:410-17
31. Korner A, Pawelek J. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 1982;217:1163-65
32. Orlow SJ, Chakraborty AK, Boissy RE, et al. Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers. Exp Cell Res 1990;191:209-18
33. Varela JM, Stempels NA, Vanden Berghe DA, et al. Isoenzymic patterns of tyrosinase in the rabbit choroid and retina/retinal pigment epithelium. Exp Eye Res 1995;60:621-29